FDA Inspection 1122793 — Johnson & Johnson Consumer Inc

Johnson & Johnson Consumer Inc — FEI 2010632

The FDA completed an inspection of Johnson & Johnson Consumer Inc on March 11, 2020 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 11, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Los Angeles, CA (United States)